New meningitis vaccine shows promise in protecting infants
NCT ID NCT05093829
First seen Apr 02, 2026 · Last updated May 05, 2026 · Updated 5 times
Summary
This study tested a new vaccine (NmCV-5) that protects against five types of meningitis bacteria in healthy infants in Mali. About 1,300 babies received either the new vaccine or an existing one at 9 or 15 months old. The goal was to see if the new vaccine is as safe and effective at triggering immune protection as the current vaccine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre pour le Developpement des Vaccins du Mali
Bamako, Mali
Conditions
Explore the condition pages connected to this study.